Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and
exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases.
The Cabaletta Approach to selective B cell Ablation (CABA™) platform, in combination with Cabaletta’s proprietary technology, utilizes
Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to selectively bind and eliminate only specific autoantibody-producing B
cells while sparing normal antibody-producing B cells, which are essential for human health. The Company’s lead product candidate,
DSG3-CAART, is being evaluated in the DesCAARTes™ Phase 1 clinical trial as a potential treatment for patients with mucosal pemphigus
vulgaris, a prototypical B cell-mediated autoimmune disease. The FDA granted Fast Track Designation for DSG3-CAART in May 2020. For
more information about the DesCAARTes™ Phase 1 clinical trial, please see www.clinicaltrials.gov. The Company’s lead preclinical
product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated
myasthenia gravis. For more information, visit www.cabalettabio.com.
Location: United States, Pennsylvania, Philadelphia
Member count: 11-50
Total raised: $125M
Founded date: 2017
Investors 1
Date | Name | Website |
- | 5AM Ventur... | 5amventure... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
28.10.2019 | IPO | $75M | - | - |
09.01.2019 | Series B | $50M | - | 5amventure... |
Mentions in press and media 14
Date | Title | Description | Category | Author | Source |
08.12.2022 | Cabaletta ... | /EIN News/ -- PHILADELPHIA, De... | - | - | einpresswi... |
08.12.2022 | Cabaletta ... | - | - | - | globenewsw... |
11.10.2022 | IASO Bioth... | PHILADELPHIA and SAN JOSE, Cal... | - | - | en.prnasia... |
30.03.2022 | A team at ... | The future of CAR-T cell thera... | - | Josh Sulli... | endpts.com... |
28.10.2019 | University... | Clinical-stage biotech company... | - | - | technical.... |
09.01.2019 | Cabaletta ... | Cabaletta Bio Inc., a Radnor, ... | USA | - | finsmes.co... |
08.01.2019 | Term Sheet... | THE STUDENT DEBT BUBBLE Good ... | - | - | fortune.co... |
08.01.2019 | Daily fund... | LendingFront raised $4M; Heads... | - | Kristin Ka... | vator.tv/n... |
06.01.2019 | Cabaletta ... | Radnor, Pennsylvania-based Cab... | - | - | medcitynew... |
03.01.2019 | Cabaletta ... | RADNOR, Pa., Jan. 03, 2019 (GL... | - | - | citybizlis... |
Show more